Researchers translate a hypothesis into a personalized treatment for cancer
Dr. Franz Zemp, Ph.D., gets chills talking about how his idea to target a specific cancer cell has evolved.
Dec 1, 2023
0
38
MeSH tree: D20.215.894.200
Dr. Franz Zemp, Ph.D., gets chills talking about how his idea to target a specific cancer cell has evolved.
Dec 1, 2023
0
38
Cancer immunotherapy has brought major improvement in patient survival and quality of life, especially with the success of adoptive T cell and immune checkpoint inhibitor therapies. Unfortunately, in contrast to different ...
Jul 13, 2023
0
43
Engineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. However, it hasn't worked as well for solid tumors.
Jul 5, 2023
0
54
Immune checkpoint blockade therapies have been revolutionary in the treatment of some cancer types, emerging as one of the most promising treatments for diseases such as melanoma, colon cancer and non-small cell lung cancer.
May 15, 2023
0
79
The U.K. government recently announced that it is partnering with German firm BioNTech to test vaccines for cancer and other diseases. The project aims to build on the mRNA vaccine technology that BioNTech became famous for ...
Jan 13, 2023
0
102
An experimental therapeutic cancer vaccine induced two distinct and desirable immune system responses that led to significant tumor regression in mice, report investigators from the National Institute of Allergy and Infectious ...
Nov 10, 2022
0
553
The cells of a subset of myeloproliferative neoplasms (MPNs), slow-growing blood cancers, have frameshift mutations in their calreticulin (CALR) gene that are associated with the disease. The tail end of this gene's mutated ...
Sep 20, 2022
0
41
Researchers around the world have been working for years on developing vaccines against different types of cancer, but without much success. Now, Tufts School of Engineering researchers think they have found one that does ...
Aug 16, 2022
0
2218